1. Macrophages protect mycoplasma-infected chronic myeloid leukemia cells from natural killer cell killing.
- Author
-
Choo QWW, Koean RAG, Chang SC, Chng WJ, Chan MC, Wang W, Er JZ, and Ding JL
- Subjects
- Adaptive Immunity, B-Lymphocytes immunology, Cell Differentiation immunology, Cell Line, Tumor, Cell Survival immunology, Coculture Techniques, Cytokines metabolism, Cytotoxicity, Immunologic, GPI-Linked Proteins immunology, GPI-Linked Proteins metabolism, Humans, Interleukin-8 metabolism, Killer Cells, Natural metabolism, Leukemia, Myelogenous, Chronic, BCR-ABL Positive enzymology, Leukemia, Myelogenous, Chronic, BCR-ABL Positive metabolism, Leukemia, Myelogenous, Chronic, BCR-ABL Positive microbiology, Macrophages microbiology, Receptors, IgG immunology, Receptors, IgG metabolism, Tissue Inhibitor of Metalloproteinase-1 pharmacology, Transforming Growth Factor beta metabolism, Inflammation immunology, Killer Cells, Natural immunology, Leukemia, Myelogenous, Chronic, BCR-ABL Positive immunology, Macrophages immunology, Mycoplasma immunology
- Abstract
Macrophages (Mϕ) have been reported to downmodulate the cytotoxicity of natural killer (NK) cell against solid tumor cells. However, the collaborative role between NK cells and Mϕ remains underappreciated, especially in hematological cancers, such as chronic myeloid leukemia (CML). We observed a higher ratio of innate immune cells (Mϕ and NK) to adaptive immune cells (T and B cells) in CML bone marrow aspirates, prompting us to investigate the roles of NK and Mϕ in CML. Using coculture models simulating the tumor inflammatory environment, we observed that Mϕ protects CML from NK attack only when CML was itself mycoplasma-infected and under chronic infection-inflammation condition. We found that the Mϕ-protective effect on CML was associated with the maintenance of CD16 level on the NK cell membrane. Although the NK membrane CD16 (mCD16) was actively shed in Mϕ + NK + CML trioculture, the NK mCD16 level was maintained, and this was independent of the modulation of sheddase by tissue inhibitor of metalloproteinase 1 or inhibitory cytokine transforming growth factor beta. Instead, we found that this process of NK mCD16 maintenance was conferred by Mϕ in a contact-dependent manner. We propose a new perspective on anti-CML strategy through abrogating Mϕ-mediated retention of NK surface CD16., (© 2019 The Authors. Immunology & Cell Biology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.)
- Published
- 2020
- Full Text
- View/download PDF